Back
Kymera Therapeutics Stock Price Chart
Fed rate cuts could send the stock market down
Here's my #1 free indicator to use now.
Buy
58
KYMR
Kymera Therapeutics
Last Price:
45.31
Seasonality Move:
17.96%
7 Day Trial
ALL ACCESS PASS
$
7
1-day winners in this choppy market
Get the 1-day winners strategy here.- The current trend is moderately bullish and KYMR is experiencing slight selling pressure.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.97 | Sell |
| 20-day SMA: | 46.18 | Buy |
| 50-day SMA: | 42.65 | Buy |
| 200-day SMA: | 35.44 | Buy |
| 8-day EMA: | 46.57 | Sell |
| 20-day EMA: | 45.95 | Buy |
| 50-day EMA: | 43.11 | Buy |
| 200-day EMA: | 36.01 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | -53339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.25 - 48.01) | Buy |
| Bollinger Bands (100): | (32.65 - 44.29) | Buy |
Kymera Therapeutics Technical Analysis
| Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 46.19 while KYMR 8-day simple moving average is 46.97, which is a Sell signal.
- The stock price of KYMR is 46.19 while Kymera Therapeutics 20-day SMA is 46.18, which makes it a Buy.
- Kymera Therapeutics 50-day simple moving average is 42.65 while KYMR share price is 46.19, making it a Buy technically.
- KYMR stock price is 46.19 and Kymera Therapeutics 200-day simple moving average is 35.44, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Buy
The current Kymera Therapeutics [KYMR] share price is $46.19. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
2.85B
Price in USD:
46.19
Share Volume:
241.81K
Kymera Therapeutics 52-Week Range
52-Week High:
50.19
52-Week Low:
9.60
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 46.19 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 46.19 while KYMR 8-day exponential moving average is 46.57, which is a Sell signal.
- The stock price of KYMR is 46.19 while Kymera Therapeutics 20-day EMA is 45.95, which makes it a Buy.
- Kymera Therapeutics 50-day exponential moving average is 43.11 while KYMR share price is 46.19, making it a Buy technically.
- KYMR stock price is 46.19 and Kymera Therapeutics 200-day simple moving average is 36.01, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is 1.16, suggesting Kymera Therapeutics is a Buy
- Kymera Therapeutics Relative Strength Index (RSI) is 53.14, which suggest Kymera Therapeutics is overbought
- The Bollinger Bands (25) for Kymera Therapeutics is (42.25 - 48.01), which suggest Kymera Therapeutics is a Buy
- The Bollinger Bands (100) for Kymera Therapeutics is (32.65 - 44.29), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.